These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 2398880)
1. [Sex hormone-binding globulin in breast cancer]. Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880 [TBL] [Abstract][Full Text] [Related]
2. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women. Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713 [TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142 [TBL] [Abstract][Full Text] [Related]
4. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women. Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657 [TBL] [Abstract][Full Text] [Related]
5. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642 [TBL] [Abstract][Full Text] [Related]
6. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients. Murayama Y Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084 [TBL] [Abstract][Full Text] [Related]
7. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1). Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513 [TBL] [Abstract][Full Text] [Related]
8. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037 [TBL] [Abstract][Full Text] [Related]
9. [Competitive binding assay with dextran-coated charcoal for measurement of sex hormone-binding globulin in breast cancer]. Suminaga Y; Sonoo H; Morimoto T Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):341-9. PubMed ID: 2423861 [TBL] [Abstract][Full Text] [Related]
10. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene. Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658 [TBL] [Abstract][Full Text] [Related]
11. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study. Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200 [TBL] [Abstract][Full Text] [Related]
12. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study. Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341 [TBL] [Abstract][Full Text] [Related]
13. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls. Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371 [TBL] [Abstract][Full Text] [Related]
14. Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency. Teruel M; Bolufer P; Rodriguez A; Antonio P; Salabert MT Exp Clin Endocrinol; 1989 Apr; 93(1):37-44. PubMed ID: 2737240 [TBL] [Abstract][Full Text] [Related]
15. Sex hormone-binding globulin and estrogen receptor in breast cancer: technique and preliminary clinical results. Murayama Y; Sakuma T; Udagawa H; Utsunomiya J; Okamoto R; Asano K J Clin Endocrinol Metab; 1978 Jun; 46(6):998-1006. PubMed ID: 263661 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability of estradiol as a marker for breast cancer risk assessment. Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208 [TBL] [Abstract][Full Text] [Related]
17. Relationship between sex hormone binding globulin and estrogen receptors in breast cancer. Plymate SR; Stutz FH; Fariss BL J Clin Oncol; 1984 Jun; 2(6):652-4. PubMed ID: 6539364 [TBL] [Abstract][Full Text] [Related]
18. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values. Endogenous Hormones and Breast Cancer Collaborative Group Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737 [TBL] [Abstract][Full Text] [Related]
19. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity]. Murayama Y Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230 [TBL] [Abstract][Full Text] [Related]
20. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise. Tymchuk CN; Tessler SB; Barnard RJ Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]